Additionally, we demonstrate that TLR7-treated CB-pDCs promote a strong inflammatory environment in co-culture with cells from tumor digests of CRC patients suggesting a potential to recruit and activate effector cells. The gene discussed is TLR7; the disease is neoplasm.